**Safety of RSV Preventive Monoclonal Antibody Study** This study looks at how safe it is to give a special medicine called RSV preventive monoclonal antibody along with other regular vaccines for babies. RSV stands for Respiratory Syncytial Virus, which can affect infants. Monoclonal antibodies are lab-made proteins that help fight infections. The study compares giving the RSV antibody and vaccines at the same time or at different visits. Parents will watch for fever and other side effects for 7 days after each visit. Serious side effects will be tracked throughout the study. Babies between 6 and 30 weeks old, who are eligible for the RSV antibody and other vaccines, can join. Parents must agree to participate and follow up with the study team. **Key Points:** - **Length of Study:** Parents need to track side effects for 7 days after each visit. - **Visits:** Babies may need to visit the clinic twice. - **Eligibility:** Babies need to be between 6 to 30 weeks old and able to get RSV antibodies. Parents should consider the time commitment and follow-up requirements when deciding to participate.